Información del producto
TLR2-IN-C29 is a novel compound that activates the AMPK pathway. This compound has been shown to have anti-cancer effects on HL60 cells and cervical cancer cells. The mechanism of action for TLR2-IN-C29 is not yet clear, but it may be due to its ability to activate methyl eicosanoate production, which inhibits the production of proinflammatory cytokines in macrophages and dendritic cells. TLR2-IN-C29 also has the potential to be used as a biomarker for autoimmune diseases such as liver cirrhosis and rheumatoid arthritis.
Propiedades químicas
Consulta técnica sobre: 3D-NPA60092 TLR2-IN-C29
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
